VIYASH · Health Care · 2026-08-07

Viyash Scientific Ltd

MARKET: BULL TOPPING · 2026-08-07

₹277

+1.60% today

₹12,090 Cr · Mid cap

About this companyHealth Care· Pharmaceuticals

Expand ▾

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.

Visit company website →

P/E (TTM)

62.4

Forward 18.8

Earnings Growth (YoY)

+228.4%

Revenue +129.0%

ROE

+11.6%

Profit margin +5.2%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 29

1w13w26w

Week 29 — mature, watch for distribution

How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.88x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

MA20 rolling over · -3.5% vs MA50 +5.9%

Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.

Sector

Health Care

↑ Building

Stage 2%

51.6%

20d Δ

+1.6pp

1M return

+3.1%

3M return

+11.6%

Sector Stage-2 % · last 20 days

Sector has 79 Stage 2 leaders. See Health Care Stage 2 →

Industry

Pharmaceuticals

→ Flat

Stage 2%

50.5%

20d Δ

+0.5pp

1M return

+1.9%

3M return

+11.7%

Industry Stage-2 % · last 20 days

Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →

Price + Volume Chart

Loading price chart…

Stage Cycle Timeline2026-01-14 → 2026-08-07

S? 29w

2026-01-142026-08-07

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 29w current

Total tracked: 29 weeks across 1 stage run.

-1.4%

+26.1%

+35.6%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-08-07S—

Wk 29 · Vol —x

2026-08-06S—

Wk 29 · Vol —x

2026-08-05S—

Wk 28 · Vol —x

2026-08-04S—

Wk 28 · Vol —x

2026-08-03S—

Wk 28 · Vol —x

2026-07-31S—

Wk 28 · Vol —x

2026-07-30S—

Wk 28 · Vol —x

2026-07-29S—

Wk 27 · Vol —x

2026-07-28S—

Wk 27 · Vol —x

2026-07-27S—

Wk 27 · Vol —x

2026-07-24S—

Wk 27 · Vol —x

2026-07-23S—

Wk 27 · Vol —x

Sector Peers — Stage 2All →

DIVISLAB

wk 12 · -3.6% from hi

8.5

LAURUSLABS

wk 16 · -0.3% from hi

8.4

PPLPHARMA

wk 4 · 0.0% from hi

8.2

LALPATHLAB

wk 9 · 0.0% from hi

7.9

SHILPAMED

wk 13 · 0.0% from hi

7.8

Moving averages & range

50 DMA

₹264.6

200 DMA

—

52W High

—

52W Low

—

5D Low

₹263.7

Resistance levels (recent highs)

20d High

₹284.4

60d High

₹294.2

120d High

₹294.2

250d High

—

Next resistance

+2.7%

to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.